Summary: MCT1(SLC16A1) is the first member of the monocarboxylate transporter (MCT) and its family is involved in the transportation of metabolically important monocarboxylates such as lactate, pyruvate, acetate and ketone bodies. This study identifies genetic variations in SLC16A1 in the ethnic Chinese group of the Singaporean population (n＝95). The promoter, coding region and exon-intron junctions of the SLC16A1 gene encoding the MCT1 transporter were screened for genetic variation in the study population by DNA sequencing. Seven genetic variations of SLC16A1, including 4 novel ones, were found: 2 in the promoter region, 2 in the coding exons (both nonsynonymous variations), 2 in the 3? untranslated region (3?UTR) and 1 in the intron. Of the two mutations detected in the promoter region, the -363-855TÀC is a novel mutation. The 1282GÀA (Val428Ile) is a novel SNP and was found as heterozygotic in 4 subjects. The 1470TÀA (Asp490Glu) was found to be a common polymorphism in this study. Lastly, IVS3-17AÀC in intron 3 and 2258 (755)AÀG in 3?UTR are novel mutations found to be common polymorphisms in the local Chinese population. To our knowledge, this is the first report of a comprehensive analysis on the MCT1 gene in any population.
Introduction
The monocarboxylate transporter (MCT) family currently comprises 14 proteins, of which the first four members (MCT1-MCT4) are involved in the transportation of metabolically important monocarboxylates such as lactate, pyruvate, acetate and ketone body in a protonmediated manner. [1] [2] [3] Of these, MCT1 (SLC16A1) and MCT4 (SLC16A3) have been reported to play vital roles in the influx and efflux of lactate across plasma membranes. As large amounts of lactic acid are constantly produced in anaerobic glycolytic tissues (such as white skeletal muscle, red blood cells and tumor cells), the efflux of lactic acid must keep pace with its production to prevent a drop in intracellular pH. 1, 2) In other tissues (such as red skeletal muscle, brain and heart), lactic acid is transported into cells and utilized as respiratory fuel. In the liver and kidneys, lactic acid is transported into cells for gluconeogenesis and lipogenesis. 1) Hence, MCTs play critical role in the metabolism and pH regulation of cells, removing lactic acid produced by glycolysis and allowing the uptake of lactic acid by oxidative tissues that utilize it as a major respiratory fuel.
MCTs may also have roles in the transport of pharmacologically active compounds, which generally consist of weak organic monovalent acids, with a carboxyl attached to a relatively small R group. 4) These include statins such as lovastatin, simvastatin and atorvastatin. Nagasawa et al. reported that lovastatin is taken up into bovine kidney NBL-1 cells and rat mesangial cells via MCT, with kinetic evidence suggesting that MCT4 is the isoform responsible for lovastatin uptake. 5, 6) However, rat cultured mesangial cells and bovine kidney NBL-1 cells used by Nagasawa et al. were shown to express other MCT isoforms; the involvement of other MCT isoforms cannot thus be excluded. MCTs might also mediate simvastatin uptake into the brain as simvastatin transport is competitively inhibited by acetate. 7, 8) MCT1 has been reported to play a part in the uptake of gammahydroxybutyrate (GHB) across the blood-brain barrier, 9) the absorption of nicotinic acid in the intestine, 10) as well as the transportation of salicylic acid and valproic acid. 11) In many tissues, more than one MCT isoform is expressed. The cellular distribution of MCT isoforms suggests an intercellular shuttle of lactic acid between different cell types. One well-documented example is the shuttle of lactic acid in skeletal muscle. MCT1 and MCT4 have been reported to be the major MCT isoforms in skeletal muscle 2, [12] [13] [14] [15] and this appears correlated with either the influx or efflux of lactic acid into different muscle fibre types. 2) MCT1 expression is the most predominant isoform in oxidative red fibres, whereas MCT4 expression is high in glycolytic white fibres. 14, 16) As glycolytic white fibres are the primary source of lactate formation via anaerobic glycolysis, MCT4 may work as an efflux transporter to mediate the transport of lactic acid out into the interstitial fluid, to be taken up by red oxidative fibres that express primarily MCT1. 2, [12] [13] [14] [15] 17) Mutations in these transporters may provide an explanation for some pathophysiological conditions. In fact, defects in MCT1 have already been shown to associated with lactate transport deficiency in red blood cells and muscle tissues by Fishbein back in 1986. 18) In 2000, Merezhinskaya et al. reported three missense mutations in MCT1 in five patients with symptomatic deficiency in lactate transport (SDLT). 19) Of these, Lys204Glu and Glu472Gly were presumably responsible for subnormal lactate transport, while Asp490Glu was proven to be a common polymorphism in the normal cohort. However, Lys204Glu was subsequently demonstrated in vitro to have no effect on lactate transport. 2) Although, this study did not comprehensively dissect the entire coding region of the gene and only selected SNPs (Lys204Glu, Glu472Gly and Asp490Glu) were screened in 79-90 normal subjects, Merezhinskaya et al. has nonetheless conducted the first search for clinically relevant mutations in the MCT1 gene. 19) The main objectives of this study were therefore to: 1) describe the single nucleotide polymorphisms in the promoter, exons and exon-intron junctions of SLC16A1 encoding MCT1 that may be present in the ethnic Chinese group of the Singaporean population and 2) predict the effects of SNPs reported in this study using bioinformatics tools. To our knowledge, this is the first report on the comprehensive analysis of MCT1 gene in any population.
Materials and Methods
Human genomic DNA samples: Genetic materials used in this study were randomly selected from a previously-developed cell repository from healthy volunteers of Chinese descent. The fully anonymized white cell lines developed from 95 individuals of ethnic Chinese of the Singaporean population were screened in this study. All donors had been recruited previously in accordance with the requirements of the ethical review board of the National University Hospital, Singapore and provided written informed consent. The mean age was 24.0±5.2 (18-48) and the male:female sex ratio was 48:47. Ethnicity was defined through self-declaration by the donors of similar ethnicity through three generations. Genomic DNA was extracted from the immortalized lymphocytes by standard methods.
PCR and sequence analysis: The promoter and exonic fragments for the SLC16A1 gene were generated using self-designed primer sequences. These primers were designed using Primer3 software (Whitehead Institute for Biomedical Research, Cambridge, MA, USA; http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_ www.cgi). A section between bases -1418 and ＋217 was screened for MCT1 promoter region (GenBank accession: NM_003051). 20, 21) Amplifications were performed in a total volume of 30 ml containing 1 X Master Mix (Promega, Madison, USA), 0.4 mM of each primer (Research Biolabs, Singapore) and 60 ng of DNA. The PCR conditions were pre-denaturation at 959 C for 5 min, followed by 35 cycles of denaturation at 959 C for 1 min, annealing for 1 min, and extension at 729 C for 1 min, and then a final extension at 729 C for 10 min. Annealing temperatures for the fragments of MCT1 gene are summarized in Table 1 .
Mutational analysis: Mutational analysis of the candidate genes was performed using a BigDye Terminator v3.1 Cycle Sequencing Kit and run on the automated ABI Prism Model 3100 Avant Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). In this study, all PCR products were subjected to DNA sequencing. The sequences were analyzed with a Mutation Surveyor TM v2.61 (Softgenetics, State College, PA, USA) and Chromas (Techelysium software). PCR was repeated and bidirectional sequencing performed on all detected variants to rule out PCR-induced mutations and sequencing artefacts. The PolyPhen program was used to predict the possible impact of amino acid substitution on structure and functions of a human protein (http://genetics.bwh. harvard.edu/pph/). Putative transcription factor binding sites were identified using the MatInspector licensed software (Library version: Matrix Library 8.0).
Results and Discussion
Sequence analysis on 95 Chinese subjects resulted in the identification of 7 genetic variants in MCT1, of which 4 are novel mutations ( Table 2) . Of these variants, 2 are located in the promoter region, 2 in the coding exons (both are nonsynonymous mutations), 2 in the 3? untranslated region (3?UTR) and 1 in the intron. Of the two mutations detected in the promoter region, -363-855TÀC is a novel mutation. Both nonsynonymous variants are present in exon 5 of MCT1, of which 1282GÀA (Val428Ile) is a novel SNP and was found as heterozygotic a Novel variations detected in this study (Search completed: Feb 2009). b A of the translation initiation codon ATG is numbered 1 (NM_003051.3 was used as the reference sequence). c The transcription initiation site is designated as -363 as it is 363 bases upstream of translation start site. The nucleotide upstream of transcription initiation site is designated as -363-n accordingly. n＝number of nucleotide 471 Population Genetic Variations of MCT1(SLC16A1) Gene in 4 subjects. The 1470TÀA (Asp490Glu) variant was found to be a common polymorphism in this study, with a frequency similar to that reported in a Caucasian population. 19) Lastly, IVS3-17AÀC in intron 3 and 2258 (755)AÀG in 3?UTR are common novel variants in the local Chinese population. The electrophoregrams of the four novel variants of SLC16A1 are shown in Figure 1 .
SLC16A1 gene spans approximately 44 kb and is mapped onto chromosome band 1p13.2-p12 in humans. 22) MCT1 has 5 exons and 4 introns and is predicted to have 500 amino acids and 12 transmembrane (TM) spanning regions. 3) Based on putative protein topology, 1282GÀA (Val428Ile) is located at the TM12. 3) A substitution from G to A at position 1282 resulted in the conversion of amino acid valine to isoleucine at position 428 of MCT1 protein. Both amino acid residues are non-polar and thus this mutation is unlikely to affect the functions of the protein. This is consistent with the results obtained using the PolyPhen program, an online tool which predicts the possible impact of amino acid substitution on the structure and functions of a human protein. The 1282GÀA (Val428Ile) variant was predicted to be benign based on position-specific independent count (PSIC) score differences.
Sequence analysis of MCT1 gene also revealed a common SNP, 1470TÀA (Asp490Glu). This SNP was previously reported by Merezhinskaya et al. 19) In this study, the allele frequencies of T and A are 34.7% and 65.3% respectively, with an average heterozygosity of 51%. As glutamic acid and aspartic acid are both acidic amino acids with similar physico-chemical properties, it is likely that substitution will not result in fundamental change. This is consistent with the results obtained using PolyPhen which predicted this SNP to be benign and unlikely to have any significant effect on protein function.
The -363-100CÀG and -363-855TÀC mutations were detected in the promoter region of MCT1, of which -363-855TÀC is novel. Recently, the promoter region of MCT1 has been characterized and found to have no TATA-Box motif and to be GC-rich. 20) The GC-rich sequence is a characteristic of TATA-less promoters that usually contain stimulating protein 1 (Sp1) binding sites. These Sp1 binding sites interact with the GC-box and play crucial roles in start site selection. 23, 24) In this study, three Sp1 binding sites were detected within the GC-rich region of the transcription initiation site. As the -363-100CÀG mutation is located at the consensus sequence of the Sp1 binding site, it is likely to affect the transcriptional regulation of the MCT1 gene. The -363-855TÀC mutation is located within the nuclear factor of activated T-cells (NFAT) binding site. As NFAT is likely to be a regulator of immune response, the -363-855TÀC may affect the regulation of MCT1 transcription during such a response. 25) In conclusion, a total of 7 genetic variants was detected in the SLC16A1 gene, of which four were novel. Both nonsynonymous variants, 1282GÀA (Val428Ile) and 1470TÀA (Asp490Glu), were predicted to be benign and may not have significant functional effects. However, the -363-100CÀG and -363-855TÀC variants may affect the transcriptional regulation of MCT1. Prediction of the effects of SNPs on the variant protein based on computational modeling location and the physiochemical properties of the amino acids can only be speculative at this moment. The true role of SNPs may only be clarified through functional assay. Nevertheless, the findings of the present study may provide fundamental information for conducting further study on the MCT1 transporter.
